Skip to menu Skip to content Skip to footer

2005

Journal Article

Measurement of kidney function

Mathew, T. and Johnson, D. W. (2005). Measurement of kidney function. Medical Observer, 29 July 2005, 29-31.

Measurement of kidney function

2005

Journal Article

Impact of obesity on renal transplant outcomes

Armstrong, Kirsten A., Campbell, Scott B., Hawley, Carmel M., Johnson, David W. and Isbel, Nicole M. (2005). Impact of obesity on renal transplant outcomes. Nephrology, 10 (4), 405-413. doi: 10.1111/j.1440-1797.2005.00406.x

Impact of obesity on renal transplant outcomes

2005

Conference Publication

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

Gobe, G., Li, J., Pat, B., Yan, J., Vesey, D., Johnson, D. and Nicol, D. (2005). Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, 4-8 September 2005, Carlton, Victoria. Blackwell Science: 1320-5358 (print); 1440-1797 (electronic). doi: 10.1111/j.1440-1797.2005.00461.x

Role of PKC-a and -e in cytotoxic chemotherapy of renal cell carcinomas

2005

Book Chapter

The Influence of Obesity on Outcomes in End-Stage Renal Failure

Wiggins, Kathryn J. and Johnson, David W. (2005). The Influence of Obesity on Outcomes in End-Stage Renal Failure. Body Mass Index and Health. (pp. 43-57) edited by Linda A. Ferrara. New York: Nova Science.

The Influence of Obesity on Outcomes in End-Stage Renal Failure

2005

Journal Article

Comparative Analysis of Caspase Activation and Apoptosis in Renal Tubular Epithelial Cells and Renal Cell Carcinomas

Davidson, Keryn, Percy, Christine, Rennick, Alina J., Pat, Betty K., Li, Jun, Nicol, David, Johnson, David W. and Gobe, Glenda C. (2005). Comparative Analysis of Caspase Activation and Apoptosis in Renal Tubular Epithelial Cells and Renal Cell Carcinomas. Nephron Experimental Nephrology, 99 (4), e112-e120. doi: 10.1159/000083926

Comparative Analysis of Caspase Activation and Apoptosis in Renal Tubular Epithelial Cells and Renal Cell Carcinomas

2005

Conference Publication

Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients

Armstrong, Kirsten, Elliott, Anne Maree, Prins, Johannes, Beller, Elaine, Campbell, Scott B., Hawley, Carmel, Johnson, David W. and Isbel, Nicole (2005). Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients. 6th American Transplant Congress, Seattle, WA, USA, 21-25 May, 2005. Oxford, England: Blackwell Publishing. doi: 10.1111/j.1600-6135.2005.abstracts.x

Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients

2005

Journal Article

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

Mudge, David W., Rogers, Robyn, Hollett, Peter, Law, Belinda, Reiger, Kylie, Petrie, James J. B., Price, Lee, Johnson, David W., Campbell, Scott B., Isbel, Nicole M., Sullivan, Matthew and Hawley, Carmel M. (2005). Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance. Nephrology Dialysis Transplantation, 20 (10), 2178-2185. doi: 10.1093/ndt/gfh987

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

2005

Other Outputs

Clinical practice guidelines for the diagnosis and management of lymphoma

Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party, Johnson, David and et al. (2005). Clinical practice guidelines for the diagnosis and management of lymphoma. Sydney, Australia: The Cancer Council Australia; Australian Cancer Network.

Clinical practice guidelines for the diagnosis and management of lymphoma

2005

Conference Publication

Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways

Rajandram, R., Pat, B., Li, J., Percy, C., Vesey, D., Johnson, D. W. and Gobe, G. (2005). Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways. 5th Annual Health and Medical Research Conference of Queensland, Brisbane, Queensland, 3-4 November, 2005. Brisbane, Queensland: Queensland Health.

Resistance to cancer treatments in renal cell carcinoma: Discovering novel apoptosis pathways

2005

Conference Publication

Nuclear factor kappaB (NF-κB) inhibition exerts pro-apoptotic and anti-proliferative effects in renal cell carcinoma (RCC) cell lines

Morais, Christudas, Westhuyzen, Justin, Pat, Betty, Gobe, Glenda, Johnson, David and Healy, Helen (2005). Nuclear factor kappaB (NF-κB) inhibition exerts pro-apoptotic and anti-proliferative effects in renal cell carcinoma (RCC) cell lines. American Society of Nephrology Renal Week, Philadelphia, Pennsylvania, USA, 8-13 November, 2005. Washington, D.C. U.S.A.: American Society of Nephrology.

Nuclear factor kappaB (NF-κB) inhibition exerts pro-apoptotic and anti-proliferative effects in renal cell carcinoma (RCC) cell lines

2005

Conference Publication

Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin

Gobe, G., Yamada, M., Pat, B., Vesey, D. and Johnson, D. W. (2005). Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin

2005

Journal Article

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

Mudge, David W., Johnson, David W., Isbel, Nicole M., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2005). Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor). Nephrology Dialysis Transplantation, 20 (1), 246-247. doi: 10.1093/ndt/gfh580

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

2005

Book Chapter

Kidney disease

Johnson, David W. and Mathew, Timothy (2005). Kidney disease. Guidelines for preventive activities in general practice. (pp. xx-xx) edited by M. Harris, L. Bailey, C. Bridges-Webb, L. Furler, B. Joyner, J. Litt, J. Smith and Y. Zurynski. Melbourne, Vic.: Royal Australasian College of General Practitioners.

Kidney disease

2005

Journal Article

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants

Pat, Betty, Yang, Tao, Kong, Chuize, Watters, Dianne, Johnson, David W. and Gobe, Glenda (2005). Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants. Kidney International, 67 (3), 931-943. doi: 10.1111/j.1523-1755.2005.00157.x

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: Modulation by antioxidants

2005

Conference Publication

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

Armstrong, K., Elliott, A. M., Prins, J., Beller, E., Campbell, Scott B., Hawley, C., Johnson, David W. and Isbel, N. (2005). Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients. 6th American Transplant Congress, Seattle, WA, U.S.A., 21-25 May 2005. Oxford, U.K.: Blackwell Publishing. doi: 10.1111/j.1600-6135.2005.abstracts.x

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

2005

Journal Article

The influence of obesity on the development and survival outcomes of chronic kidney disease

Wiggins, Kathryn J. and Johnson, David W. (2005). The influence of obesity on the development and survival outcomes of chronic kidney disease. Advances In Chronic Kidney Disease, 12 (1), 49-55. doi: 10.1053/j.ackd.2004.10.014

The influence of obesity on the development and survival outcomes of chronic kidney disease

2005

Book Chapter

Post-transplant lymphoproliferative disorder

Johnson, David (2005). Post-transplant lymphoproliferative disorder. Clinical Practice Guidelines for the Diagnosis and Management of Lymphoma. (pp. 279-290) edited by Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party. Sydney: The Cancer Council Australia/Australian Cancer Network.

Post-transplant lymphoproliferative disorder

2005

Journal Article

Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease

Armstrong, Kirsten A., Rakhit, Dhrubo J., Case, Colin, Johnson, David W., Isbel, Nicole M. and Marwick, Thomas H. (2005). Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease. Nephrology Dialysis Transplantation, 20 (10), 2097-2104. doi: 10.1093/ndt/gfh980

Derivation and validation of a disease-specific risk score for cardiac risk stratification in chronic kidney disease

2004

Journal Article

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

Sturtevant, Joanna M., Hawley, Carmel M., Reiger, Kylie, Johnson, David W., Campbell, Scott B., Burke, John R., Bofinger, Andrew and Isbel, Nicole M. (2004). Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders. Nephrology, 9 (6), 406-413. doi: 10.1111/j.1440-1797.2004.00338.x

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

2004

Journal Article

Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits

Wojcikowski, Ken, Johnson, David W. and Gobe, Glenda (2004). Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits. Nephrology, 9 (6), 400-405. doi: 10.1111/j.1440-1797.2004.00355.x

Medicinal herbal extracts - renal friend or foe? Part two: Herbal extracts with potential renal benefits